Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Gynecologic Oncology
>
>
22
>
4
Volume:
22
Issue:
4
1. The role of neoadjuvant chemotherapy in ovarian cancer patients with extensive tumor burden.
Page:299—300
2. Paratubal serous borderline tumor.
Page:295—298
3. Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma.
Page:292—294
4. A mediastinal germ cell tumor mimicking an ectopic pregnancy.
Page:288—291
5. Diffusion-weighted MR imaging in gynecologic cancers.
Page:275—287
6. Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancer.
Page:269—274
7. Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.
Page:260—268
8. Total laparoscopic hysterectomy versus da Vinci robotic hysterectomy: is using the robot beneficial?.
Page:253—259
9. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.
Page:244—252
10. Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study.
Page:239—243
11. Synchronous gynecologic malignancy and preliminary results of Lynch syndrome.
Page:233—238
12. Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro.
Page:225—232
13. ASGO's Second Biennial Meeting, November 3-5 2011.
Page:222—224
14. Recent advances in the biomarkers for epithelial ovarian cancer.
Page:219—221